Abiraterone Tablet
Product Images NDC 72789-213

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 72789-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789213 Label (72789213)

Abiraterone Acetate is a medication that comes in tablet form. Each tablet contains 250 mg of Abiraterone Acetate, and it should be swallowed whole without crushing or chewing. The recommended dosage for this medication can be found in the accompanying product literature. It should be stored at room temperature in a tightly closed container and kept out of reach of children. Women who are or may be pregnant should not handle Abiraterone Acetate Tablets without gloves, as indicated in the package insert.*

FDA Label Image

Chemical Structure (Abiraterone Acetate Tablets 1)

FDA Label Image

Figure 1 (Abiraterone Acetate Tablets 2)

This text is not-available.*

FDA Label Image

Figure 2 (Abiraterone Acetate Tablets 3)

FDA Label Image

Figure 3 (Abiraterone Acetate Tablets 4)

FDA Label Image

Overall Survival, Intent-to-treat Population In Latitude (Abiraterone Acetate Tablets 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.